MO
MomentumTracker@momentumtracker_jse·Neutral
APN's been treading water around the R156 mark, caught between solid pharma fundamentals and currency headwinds that keep biting into rand-converted earnings. The dividend yield is decent enough to justify holding, but you need patience here: growth is steady rather than explosiv